Loading…
DIA Europe 2019 has ended
View analytic
Tuesday, February 5 • 14:00 - 15:15
#DMD4: EUnetHTA Town Hall: Impact of Health Technology Assessment when Evidence (Regulatory vs Relative), Costs and Patient Expectations are Challenging to Combine

Sign up or log in to save this to your schedule and see who's attending!

Component Type: Session



Chair

Niklas Hedberg, MPharm

Speaker

Regulator Perspective
Marie Gardmark

Payer Perspective
Robert Sauermann

Industry Perspective
Adam Parnaby



Speakers
avatar for Marie Gardmark

Marie Gardmark

Head of Licensing, Swedish Medicines Agency (MPA)
avatar for Niklas Hedberg

Niklas Hedberg

Chair EUnetHTA Executive Board, Chief Pharmacist, Dental and Pharmaceutical Benefits Agency, TLV
Niklas Hedberg, MSc, is Chief Pharmacist for the Dental and Pharmaceuticals Benefits Agency (TLV) in Sweden. He is also Chair of the EUnetHTA Executive Board, TLV’s lead partner in EUnetHTA, and has led EUnetHTA WP3 – Evaluation since 2016. Mr. Hedberg has broad experience in... Read More →
avatar for Adam Parnaby

Adam Parnaby

Senior Director Market Access Policy, Worldwide Markets, Celgene
Adam has 18 years of experience in the pharma industry and started his career as an academic health economist. Previously, he was Director of Pricing and Market Access for Celgene’s Oncology portfolio in the EMEA region. Prior to joining Celgene, he worked in Health Economics and... Read More →
avatar for Bettina Ryll

Bettina Ryll

Chair ESMO Patient Advocates Working Group (PAWG), Melanoma Patients
Bettina Ryll, MD/PhD founded the Melanoma Patient Network Europe in 2013 and developed a special interest in patient-centric clinical research and drug development. Bettina’s current areas of focus are Adaptive Licensing/ MAPPS , innovative sustainable healthcare models and patient-centered... Read More →
RS

Robert Sauermann

Department Head, Association of Austrian Social Insurance


Tuesday February 5, 2019 14:00 - 15:15
E2 Austria Center Vienna Bruno-Kreisky-Platz 1 1220 Vienna Austria
  • Featured Topics Value and Access
  • Tags Session